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I am a scientist and this is my brief on what the world needs to know about science and COVID-19.
Science is a method of truth-telling about the physical world and ways to improve quality of life. It is
the most powerful enterprise that has led to improved healthcare, a more sustainable environment,
a safer world, and a better “knowing and understanding” about the world we live in. Science is fun
and spectacular. And it has rarely let us down, until now.
Despite multiple warnings in 2015, the current global pandemic has revealed major deficits in
our preparedness for a viral attack. Governments have let the public down by not supporting early
warning programs and for not providing sufficient science funding to understand how different
people respond differently to a viral attack, and vaccine development. The present pandemic
has also revealed that science underpins a country’s national security in ways never appreciated
before. The resultant economic upheaval has thrown global supply chains, stockmarkets, the airline
industry, oil markets, and the central bank into frenzied disarray (1). It is regrettable that it took
a global pandemic, and the most powerful global economies to come crashing to their knees, with
hundreds of thousands of lives lost, to bring science out of the shadows, and into the spotlight.
For decades, politicians have conveyed to the public how their country is leading science
innovation and technology but they fail to sufficiently support it. In many areas, they are deaf to the
calls from scientists, universities and research institutions to increase funding. Scientists themselves
must also do a better job at explaining what they do and how science works. What most people
don’t understand is that science begins with a question and ends with a question (2). This is often
confusing. If science is open-ended, how does it solve problems, like those from COVID-19? The
short answer is you first have to understand what a virus is, where it has come from, how it enters
the body, what it does when it gets there, and finally how to remove it. Finding answers to these
questions raises more questions, and it is this process of knowledge-building and self-correction, that
leads to improved understanding and development of new therapies, vaccines, and technological
advances. Unlike bacteria that can thrive almost anywhere, a virus needs a living animal’s cellular
machinery for its replication and survival. Understanding how a virus has evolved the “tricks” to
enter the body “undetected” is not fully understood. And if the COVID-19 virus enters our bodies,
why do some people die a horrific death, others have flu-like symptoms, and 20 to 50% become
asymptomatic carriers (3, 4)? And why do some children, a few weeks after contracting COVID-
19, suffer a hyper-inflammatory attack and succumb to cardiovascular complications and toxic
shock? (5).
Before science can answer questions on COVID-19, scientists need to better understand how
the immune system works (6). The basic question on why some people have a very mild response,
and others die from an explosive inflammatory attack is the 64-billion-dollar question. We have
been working on new drugs to bolster a patient’s defense to a pathogen or injury, as part of the
stress response, which we believe is controlled by the brain and resides at the intersection of the
immune and inflammatory systems (7, 8). While governments are spending billions of dollars
developing a COVID-19 vaccine, we should not get complacent. Notwithstanding the global
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importance of developing a successful vaccine, it will not answer
these, and related, fundamental scientific questions. Nor is a
vaccine a substitute for the need to increase science funding,
because history will repeat itself, another pandemic will occur,
and the cycle will start over again.What we urgently need are new
frontline drugs to blunt uncontrolled inflammation, and prevent
pulmonary and cardiovascular dysfunction, coagulopathy and
metabolic impairment (8–10).
I argue here that the current financial and health crisis is a
symptom of a decade or more of budget cuts to basic scientific
research, lack of job security among scientists, and declining
interest in the next generation to pursue a career in science.
Once a research grant is submitted to a funding body, the
current success rate in the USA, Australia, UK and Europe is
around 5 to 10%, so why facing these odds would a 12th grader
or young university student want to become a scientist? The
scientist and science, like teachers and nurses, continue to be
undervalued by society. In the past decade, funding for the
US National Institutes of Health (NIH) has steadily declined,
losing around 20% of its funding capacity due to budget cuts,
sequestration, and the impact of inflation. President Trump has
proposed another 7% drop in NIH funding in 2021, and similar
reductions to other science-based agencies (11). In Australia,
government investment into research and development is at its
lowest in 40 years (12). In Europe, a giant research programme,
known as Horizon Europe, will be launched in 2021 across its 28
member states, and other countries, to fund Big Science involving
large research groups (13), which leaves the individual scientist
or small group of collaborators at a distinct disadvantage. It
also remains to be seen, what percentage of those funds will be
earmarked to support basic research, and early career scientists
to set up their laboratories, who otherwise find it challenging
to join large collaborative groups (13). Big Science is not the
answer, and history has shown that most discoveries are made
serendipitously by individual scientists thinking outside-the-box
(2, 14, 15).
Notwithstanding the relentless hyperbole by government
officials on funding, and their increasing attempts to pass the
torch to industry, many scientists, universities and research
institutions are in “survival mode” because of cut-backs.
Universities are not businesses in a strict sense; they are involved
in teaching and learning, research and technology, and job
creation, which are designed to serve the needs of society.
Industry, does, however, eventually benefit as the final receiver of
potentially translatable products, but they are rarely the primary
funders. Hopefully, the current pandemic will drive home to
politicians and lawmakers the societal role of a university, and that
the current funding schemes are not fit for purpose.
Another critical aspect of science is that a “truth” or
“fact” in science is an evidence-based statement, not just a
“subjective” feeling or an impression (2).When President Donald
Trump told the world that he thinks the antimalarial drug
hydroxychloroquine is safe and that he would take it, is not an
evidence-based statement. An evidence-based statement needs
to be tested using the tools of science and medicine, which
involves some kind of effect, measurement, human trials and
peer review. That CO2 in our atmosphere is rising has also
sparked a lot of political and public confusion with mixed
messages. The preponderance of evidence from the vast majority
of scientists specializing in this research conclude that the rise
in CO2 is associated with global warming and is accelerated
from the burning of fossil fuels, deforestation and human activity
(16). Of course, there are critics, however, the preponderance of
evidence suggests that time is running out, and the warnings
that are eerily similar to those leading up to the present
pandemic. Unexpectedly, the current global shutdown in early
2020 has also provided us with a global experiment in reducing
greenhouse gas emissions. Some countries like China decreased
emissions by up to 25%, and the people in India can now
see the snow-capped peaks of the Himalayas for the first
time in decades (17). It is important to remember that the
statement “The rise in CO2 is associated with global warming
and human activity” is not an absolute statement–it is based
on the preponderance of available evidence. Science does not
deal with absolutes or first causes, which is its power not
its weakness. A provisional-based knowledge allows science
to self-correct with improved “truths” and deliverables. This
provisional nature of science is often used to attack the process
in the media, which sends mixed messages to the public
and politicians.
Since February 2020 I have never heard the word “science”
mentioned so many times in my 30 years as a scientist, or have
I witnessed its credibility being blindly attacked for political gain.
We live in a dangerous world and we are outnumbered; 20
million viruses can fit on the head of pin. We need to embrace
these new realities, listen to the experts, and not be swayed by
the uninformed or naysayers (18–20). Now is a pivotal time
in history. I hope the current COVID pandemic has exposed
major gaps in Government funding of basic science, and that they
stop throwing out pocket-change to scientists thinking that the
problem will go away. If we do not learn from our mistakes, I fear
100 years from now historians will write: “the people of the early
twenty-first century remained imprisoned by the past and failed
to embrace the tools to break free.” Breaking free requires a new
global stewardship, with new partnership programs in education,
increased funding of basic science and technology, and a renewed
optimism that anything is possible.
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